Notice of Pre-application Webinar for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) - RFA-CA-21-038 and RFA-CA-21-039
Notice Number:
NOT-CA-21-097

Key Dates

Release Date:

July 20, 2021

Related Announcements

RFA-CA-21-038 - Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
RFA-CA-21-039 - Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice informs the applicant community that the National Cancer Institute (NCI) will hold a pre-application webinarfor Funding Opportunity Announcements (FOAs) RFA-CA-21-038 and RFA-CA-21-039, entitled "Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)" and “Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed),” respectively.

NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants to the above-referenced FOAs by explaining the goals and objectives for the proposed FOAs and answer questions from webinar attendees.

Potential applicants are encouraged to submit questions when registered to the pre-application webinar or send questions to seis@mail.nih.gov by 12:00 PM ET on August 10th, 2021.

Webinar Information:

Date: August 16, 2021

Time: 1:00 - 2:00 PM (ET)

To join the Webinar, pre-registration is required through Webex.

To register for the August 16, 2021, webinar, please go to:

Pre-application Webinar for CAP-IT Program RFAs

Specific webinar details will be provided upon registration.

Participation in this webinar, although highly encouraged, is optional and is not required for the submission applications in response to RFA-CA-21-038 and RFA-CA-21-039, respectively.

The webinar will be recorded for those who are not able to participate in the live event. A document highlighting frequently asked questions and corresponding answers will be posted, along with the webinar recording, to the following website approximately 2-3 weeks after the webinar: at CAP-IT.

Inquiries

Please direct all inquiries to:

Shizuko Sei, M.D.
Division of Cancer Prevention
National Cancer Institute (NCI)
Telephone: 240-276-5005
Email: seis@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices